CN111574416B - Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate - Google Patents
Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate Download PDFInfo
- Publication number
- CN111574416B CN111574416B CN202010475715.8A CN202010475715A CN111574416B CN 111574416 B CN111574416 B CN 111574416B CN 202010475715 A CN202010475715 A CN 202010475715A CN 111574416 B CN111574416 B CN 111574416B
- Authority
- CN
- China
- Prior art keywords
- pleuromutilin
- tiamulin
- isothiourea
- toluenesulfonate
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZRZNJUXESFHSIO-UHFFFAOYSA-N Pleuromutilin Natural products CC1C(O)C(C)(C=C)CC(OC(=O)CO)C2(C)C(C)CCC31C2C(=O)CC3 ZRZNJUXESFHSIO-UHFFFAOYSA-N 0.000 title claims abstract description 77
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 title claims abstract description 61
- 229960004885 tiamulin Drugs 0.000 title claims abstract description 61
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 title claims abstract description 60
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical compound C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 26
- 150000002541 isothioureas Chemical class 0.000 title claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 46
- 238000005406 washing Methods 0.000 claims abstract description 31
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims abstract description 28
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims abstract description 26
- -1 pleuromutilin ester Chemical class 0.000 claims abstract description 24
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims abstract description 17
- QMSVNDSDEZTYAS-UHFFFAOYSA-N 1-bromo-1-chloroethane Chemical compound CC(Cl)Br QMSVNDSDEZTYAS-UHFFFAOYSA-N 0.000 claims abstract description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 230000007935 neutral effect Effects 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 230000001105 regulatory effect Effects 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 239000012071 phase Substances 0.000 claims description 31
- XWJCLVYTQULGAW-UHFFFAOYSA-N 2-(diethylamino)ethylthiourea hydrochloride Chemical compound [Cl-].C(C)N(CCNC(S)=[NH2+])CC XWJCLVYTQULGAW-UHFFFAOYSA-N 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 15
- 230000035484 reaction time Effects 0.000 claims description 13
- 150000007529 inorganic bases Chemical class 0.000 claims description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- 150000002576 ketones Chemical class 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 8
- 239000012295 chemical reaction liquid Substances 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000012074 organic phase Substances 0.000 claims description 6
- 238000005191 phase separation Methods 0.000 claims description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 5
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- ROXZSHRRSBRWIW-UHFFFAOYSA-N 1-chloro-n,n-diethylethanamine Chemical compound CCN(CC)C(C)Cl ROXZSHRRSBRWIW-UHFFFAOYSA-N 0.000 claims 3
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 claims 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 claims 1
- HOJIHIFXRHMKLL-UHFFFAOYSA-N 1-chloroethanamine Chemical compound CC(N)Cl HOJIHIFXRHMKLL-UHFFFAOYSA-N 0.000 abstract description 14
- YBDSNEVSFQMCTL-UHFFFAOYSA-N 2-(diethylamino)ethanethiol Chemical compound CCN(CC)CCS YBDSNEVSFQMCTL-UHFFFAOYSA-N 0.000 abstract description 11
- 239000002994 raw material Substances 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000003513 alkali Substances 0.000 description 7
- 235000011121 sodium hydroxide Nutrition 0.000 description 7
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000002194 synthesizing effect Effects 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- YXQXDXAHCSEVSD-GCYNEOGWSA-N dynamutilin Chemical compound OC(=O)\C=C\C(O)=O.CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 YXQXDXAHCSEVSD-GCYNEOGWSA-N 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229940092292 tiamulin fumarate Drugs 0.000 description 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002575 chemical warfare agent Substances 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/08—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a chemical synthesis method of tiamulin serving as a veterinary raw material, in particular to a method for preparing tiamulin by using isothiourea salt and pleuromutilin p-toluenesulfonate. The method comprises the steps of preparing isothiourea salt by reacting bromochloroethane with amino chloroethane prepared by diethylamine and thiourea, preparing pleuromutilin ester of p-toluenesulfonic acid by reacting pleuromutilin with p-toluenesulfonyl chloride, adding the isothiourea salt into the pleuromutilin ester of p-toluenesulfonic acid, and carrying out alkaline washing, neutral washing, phase inversion and other extraction steps on the reaction solution to obtain the high-purity tiamulin. The invention completely avoids the regulatory dangerous intermediate diethylaminoethanethiol, adopts a milder route to prepare tiamulin, greatly reduces the product management and control cost, has easily available raw materials, and is very suitable for the application of industrialized mass production.
Description
Technical Field
The invention relates to a chemical synthesis method of a veterinary bulk drug, in particular to a method for preparing tiamulin by using isothiourea salt and pleuromutilin p-toluenesulfonate.
Background
Tiamulin fumarate is a special antibiotic for pleurotus ostreatus animals, has an antibacterial spectrum similar to that of macrolide antibiotics, and is mainly used for preventing and treating respiratory diseases of poultry. The tiamulin fumarate has the advantages of rapid absorption, high blood concentration, wide in-vivo distribution, lower residue, difficult generation of drug resistance, no pollution to the environment and the like, so the tiamulin fumarate has been popularized and used in the global scope, and the veterinary antibiotic line is ascend ten times, so that the market demand is extremely large.
Tiamulin is a semisynthetic compound, and is synthesized mainly by taking diethylaminoethanethiol as a raw material in the industry at present through the following steps. Step one: 200510122952.1 "preparation method of pleuromutilin-containing raw material in production of tiamulin", published in 8/9 2006 ", discloses fermentation extraction of pleuromutilin by higher fungus Pleurotus basidiomycetes. Step two: 201210169854.3 'a method for synthesizing pleuromutilin ester of p-toluenesulfonic acid', which is disclosed in 12/18 2013, discloses that pleuromutilin ester of p-toluenesulfonic acid is prepared by the synthesis reaction of pleuromutilin and p-toluenesulfonyl chloride under the catalysis of inorganic base. Step three: 201210169855.8 'a method for synthesizing tiamulin' disclosed in 12.18.2013 discloses nucleophilic substitution reaction of pleuromutilin ester of toluenesulfonic acid and diethylamino ethanethiol under the catalysis of inorganic base to obtain tiamulin. The main problem of this scheme is that the intermediate diethylaminoethanethiol has greater toxicity and strong pungent odor, and is the main raw material for synthesizing nitrogen mustard gas as a chemical weapon, so that the second class of monitoring chemicals which are strictly controlled by the 'forbidden chemical weapon convention' are strictly monitored in purchase and use.
In order to get rid of the restriction of purchase and use of diethylaminoethanethiol, a series of methods for preparing tiamulin which diethylaminoethanethiol is avoided as a raw material are developed. For example, 201410842597.4 ' one pot method for synthesizing tiamulin ' disclosed in 3/25/2015 ' is a ' one pot method ' in which three raw materials for producing tiamulin, pleuromutilin ester of toluenesulfonic acid, diethylamine and ethylene oxide are directly mixed together for reaction. The method avoids directly using diethylaminoethanethiol, but has the advantages of more impurities, incapability of separation, extremely low tiamulin yield, and no significance in industrial production, and the method stays in the laboratory research stage all the time.
For example, 201310068656.2, 22 days of 2013 discloses a preparation method of tiamulin alkali, which is to chlorinate hydroxyl in pleuromutilin, react with thiourea to prepare pleuromutilin thiourea salt, and then add diethylaminoethanol to obtain tiamulin alkali. A201510231192.1 'method for synthesizing tiamulin' disclosed in 9.2015, 9.9 is characterized in that p-toluenesulfonic acid pleuromutilin ester, thiourea and sodium metabisulfite are used for preparing thio-pleuromutilin, and diethylaminoethane derivative and salt thereof are added for preparing tiamulin. The 201710943351.X disclosed in 14 3.2018 is a preparation method of tiamulin, which takes compound pleuromutilin as raw material, and the compound pleuromutilin is subjected to p-toluenesulfonylation, nucleophilic substitution reaction with beta-mercaptoethanol, activation by a halogenating reagent or a sulfonylating reagent, and finally reaction with diethylamine to obtain the tiamulin. Although the three methods successfully avoid diethylaminoethanethiol, the yield of tiamulin is far lower than that of the traditional method using diethylaminoethanethiol; new management chemicals such as diethylaminoethanol, diethylaminoethane derivatives, mercaptoethanol have also been introduced; the chlorination process of the strict pipe of the national security supervision department is adopted; the above three methods are not significant in industrial production.
Disclosure of Invention
The invention aims to solve the problem of avoiding the use of monitoring chemicals and provides a safe and environment-friendly synthesis method of tiamulin suitable for industrial production.
In order to solve the problems, diethylamine and bromochloroethane are reacted, and thiourea is added to react to generate isothiourea salt; reacting pleuromutilin with p-toluenesulfonyl chloride to generate p-toluenesulfonic acid pleuromutilin ester; adding isothiourea salt into pleuromutilin p-toluenesulfonate to react to generate tiamulin, and the specific technical scheme is as follows: a, preparing the amino chloroethane, adding bromochloroethane into a reactor, heating, then gradually adding diethylamine, wherein the diethylamine feeding time is less than 1 hour, the reaction temperature is 80-120 ℃, the reaction time is maintained for 1-3 hours, cooling the reaction liquid to room temperature, adjusting the pH value to be not less than 12.0, washing, controlling the pH value to be 6.0-7.5, and separating the water phase to obtain the amino chloroethane. b, preparing diethylaminoethyl isothiourea hydrochloride, adding thiourea and water into the amino chloroethane in the step a, and maintaining the reaction temperature at 60-80 ℃ for 1.5-2.5 hours to generate 60-70% diethylaminoethyl isothiourea hydrochloride solution. And c, preparing pleuromutilin ester of the toluenesulfonic acid, adding ketone or benzene organic solvents into a reactor, adding pleuromutilin, p-toluenesulfonyl chloride and inorganic base, maintaining the pH value of a reaction system to be equal to or higher than 12, reacting at 50-60 ℃ for 0.5-1 hour, and then separating the water phase to obtain the pleuromutilin ester solution of the toluenesulfonic acid. d, reacting isothiourea salt with pleuromutilin p-toluenesulfonate, adding the diethylaminoethyl isothiourea hydrochloride solution prepared in the step b into the pleuromutilin p-toluenesulfonate solution prepared in the step c, adding tetrabutylammonium bromide and inorganic base, and reacting for 0.5-1 hour at the temperature of 50-60 ℃ to obtain tiamulin reaction solution. e, extraction of tiamulin: the tiamulin reaction liquid is separated into water phases, impurities are removed through alkaline washing, neutral washing, phase inversion and the like in sequence, the pH value of the alkaline washing is not less than 12.0, the pH value of the neutral washing is controlled to be 6.0-7.5, the water phases are transferred into the water phases at the pH value of not less than 3.0, the water phases are then transferred back to the organic phases, diethylaminoethyl isothiourea hydrochloride is 40-45 ℃, the phase separation interface is clear, the impurities are removed through washing by using a proportioning liquid of methanol and water, and finally the solvent is evaporated under reduced pressure for recycling, so that the tiamulin is obtained.
Specifically, in the preparation of the amino chloroethane in the step a, the mol ratio of bromochloroethane to diethylamine is 1:1.0-1.3.
Specifically, in the preparation of diethylaminoethyl isothiourea hydrochloride in the step b, the molar ratio of the addition amount of thiourea to the addition amount of bromochloroethane in the step a is 1:1.0-1.1.
Specifically, the ketone organic solvent is methyl isobutyl ketone or methyl ethyl ketone, and the benzene organic solvent is toluene or xylene.
Specifically, in the preparation of the pleuromutilin ester of the p-toluenesulfonic acid in the step c, the molar ratio of pleuromutilin to p-toluenesulfonyl chloride is 1:1.02-1.10.
Specifically, in the reaction of the isothiourea salt and the pleuromutilin ester of the toluenesulfonic acid in the step d, the mol ratio of the pleuromutilin ester of the toluenesulfonic acid to the diethylaminoethyl isothiourea hydrochloride is 1:1.1-1.3
Specifically, in the preparation of tiamulin by using the isothiourea salt and the pleuromutilin p-toluenesulfonate in the step d, the addition amount of tetrabutylammonium bromide is 0.5-1% of the addition amount of the pleuromutilin p-toluenesulfonate.
Specifically, the inorganic base is 32% of ionic membrane base, in the preparation of the pleuromutilin p-toluenesulfonate in the step c, the adding amount of the 32% of ionic membrane base is 45% -55% of the adding amount of the pleuromutilin, and in the preparation of tiamulin by using the isothiourea salt and the pleuromutilin p-toluenesulfonate in the step d, the adding amount of the 32% of ionic membrane base is 30% -40% of the adding amount of the pleuromutilin p-toluenesulfonate.
Specifically, in the purification of tiamulin in the step e, the addition amount of the proportioning liquid of the methanol and the water is not less than 75% of the tiamulin.
Specifically, the methanol and water mixture contains 10-40% methanol.
The tiamulin is prepared by reacting isothiourea salt with the pleuromutilin p-toluenesulfonate, the use of diethylaminoethanethiol as a monitoring chemical is completely avoided, and the yield of the tiamulin is similar to that of a diethylaminoethanethiol pathway.
Detailed Description
The method adopted by the invention is as follows:
a, preparing the amino chloroethane: bromochloroethane is added into the reactor, the temperature is raised, and then diethylamine is gradually added. The diethylamine feeding time is less than 1 hour, the feeding mole ratio of bromochloroethane and diethylamine is 1:1.0-1.3, the reaction temperature is 80-120 ℃, the reaction time is maintained for 1-3 hours, and the reaction solution is cooled to room temperature. And (3) adjusting the pH value to be not less than 12.0, washing, controlling the pH value to be 6.0-7.5, and separating the water phase to obtain the amino chloroethane.
B, preparation of diethylaminoethyl isothiourea hydrochloride: adding thiourea and water into the amino-chloroethane in the step a, wherein the molar ratio of the addition amount of the thiourea to the addition amount of the bromochloroethane in the step a is 1:1.0-1.1, the reaction temperature is 60-80 ℃, and the reaction time is maintained for 1.5-2.5 hours, thus generating 60-65% diethylaminoethyl isothiourea hydrochloride solution.
C, preparation of pleuromutilin ester of p-toluenesulfonic acid: the ketone or benzene is organic solvent, the ketone can be methyl isobutyl ketone or methyl ethyl ketone, and the benzene can be toluene or xylene. Adding pleuromutilin, p-toluenesulfonyl chloride and inorganic alkali, wherein the feeding molar ratio of the pleuromutilin to the p-toluenesulfonyl chloride is 1:1.02-1.10, the inorganic alkali can be strong alkali such as sodium hydroxide, potassium hydroxide and the like, preferably ionic membrane alkali prepared by electrolysis of an ion exchange membrane method, the adding amount of the ionic membrane alkali is 45-55% of the adding amount of the pleuromutilin, the pH value of a reaction system is maintained to be not less than 12, the reaction temperature is 50-60 ℃, the reaction time is 0.5-1 hour, and the water phase is separated and discarded to obtain the pleuromutilin p-toluenesulfonate solution.
D, reaction of isothiourea salt with pleuromutilin ester of p-toluenesulfonic acid: adding the diethylaminoethyl isothiourea hydrochloride solution prepared in the step b into the pleuromutilin ester solution prepared in the step c, and adding a catalyst tetrabutylammonium bromide and inorganic base, wherein the molar ratio of the pleuromutilin ester to the diethylaminoethyl isothiourea hydrochloride is 1:1.1-1.3, preferably the inorganic base is ionic membrane base, the adding amount of the inorganic base is 30-40% of the adding amount of pleuromutilin, and the reaction time is 0.5-1 hour at the reaction temperature of 50-60 ℃ to obtain the tiamulin reaction solution.
E, extraction of tiamulin: the tiamulin reaction liquid is firstly separated into water phases, then the water phases are sequentially subjected to alkaline washing, neutral washing, phase inversion and the like to extract and remove impurities, the pH value of the alkaline washing is not less than 12.0, the pH value of the neutral washing is controlled to be 6.0-7.5, the water phases are transferred into the water phases under the pH value of not less than 3.0, the water phases are then transferred back to the organic phases, the diethylaminoethyl isothiourea hydrochloride is 40-45 ℃, and the phase separation interface is clear. And washing with methanol and water to remove impurities, wherein the content of methanol is 10-40%, and the addition amount of the methanol and water is not less than 75% of the tiamulin. Finally, the solvent is distilled off under reduced pressure for recycling, and the high-purity tiamulin is obtained. The generated waste liquid is collected to a waste water pool for centralized treatment, and can be recycled for solution preparation or washing.
Example 1
To a 500ml reactor equipped with a stirring and condensing reflux apparatus, 143g of bromochloroethane was charged, and the temperature was raised to 80℃with the gradual addition of 73g of diethylamine over 1 hour, and then the reaction was maintained at 120℃for 1 hour, and the reaction solution was cooled to room temperature. Washing with 250ml of 30% K 2CO3, washing with 50ml of water with pH controlled at 6.0-7.5, and separating the aqueous phase to obtain the amino chloroethane.
80Ml of water and 69.2g of thiourea are added into the amino chloroethane, the reaction temperature is 60-75 ℃, the reaction is maintained for 2 hours, diethylaminoethyl isothiourea hydrochloride solution is generated, and the isothiourea salt content is detected to be 61.21 percent for standby.
200Ml of solvent methyl isobutyl ketone, 30g of pleuromutilin, 16g of p-toluenesulfonyl chloride and 15g of 32% of ionic membrane caustic soda are added into a 500ml reactor with stirring, the pH value of a reaction system is maintained to be not less than 12, the reaction temperature is 50 ℃, the reaction time is 1 hour, the water phase is separated, 228ml of pleuromutilin p-toluenesulfonate solution is obtained, and the content of pleuromutilin p-toluenesulfonate is detected to be 18.28%.
35G of diethylaminoethyl isothiourea hydrochloride solution, 0.3g of tetrabutylammonium bromide serving as a catalyst and 15g of 32% ionic membrane caustic soda are added into a ketone solution of pleuromutilin p-toluenesulfonate, and the reaction temperature is 60 ℃ and the reaction time is 0.5 hour, so that a reaction solution of tiamulin is obtained.
The tiamulin reaction liquid is separated into water phase, the pH value is adjusted to be larger than or equal to 12.0, the washing is carried out, the pH value is adjusted to be controlled within the range of 6.0-7.5, neutral washing is carried out, the water phase is transferred into the organic phase again after the pH value is smaller than or equal to 3.0, the diethylaminoethyl isothiourea hydrochloride is at the temperature of 40-45 ℃, and the phase separation interface is clear. Then, the mixture was washed with 30ml of 25% aqueous methanol solution, and the solvent was distilled off under reduced pressure at 95℃and-0.095 MPa to obtain 36.08g of tiamulin, the purity of which was detected as 96.12%.
Example 2
143G of bromochloroethane was charged into a 500ml reactor equipped with a stirring and condensing reflux apparatus, heated to 80℃and 93g of diethylamine was gradually added over 1 hour, then the reaction was maintained at 100℃for 3 hours, and the reaction solution was cooled to room temperature. Washing with 250ml of 30% K 2CO3, washing with 50ml of water with pH controlled at 6.0-7.5, and separating the aqueous phase to obtain the amino chloroethane.
80Ml of water and 75g of thiourea are added into the amino chloroethane, the reaction temperature is 65-80 ℃, the reaction is maintained for 1.5 hours, diethylaminoethyl isothiourea hydrochloride solution is generated, and the isothiourea salt content is detected to be 62.03 percent for standby.
200Ml of solvent methyl isobutyl ketone, 30g of pleuromutilin, 15.5g of p-toluenesulfonyl chloride and 15g of 32% of ionic membrane caustic soda are added into a 500ml reactor with stirring, the pH value of a reaction system is maintained to be not less than 12, the reaction temperature is 60 ℃, the reaction time is 0.5 hour, the aqueous phase is discarded, 231ml of pleuromutilin p-toluenesulfonate solution is obtained, and the content of pleuromutilin p-toluenesulfonate is detected to be 18.14%.
30G of diethylaminoethyl isothiourea hydrochloride solution, 0.3g of tetrabutylammonium bromide serving as a catalyst and 15g of 32% ionic membrane caustic soda are added into a ketone solution of pleuromutilin p-toluenesulfonate, and the reaction temperature is 50 ℃ and the reaction time is 1 hour, so that a reaction solution of tiamulin is obtained.
The tiamulin reaction liquid is separated into water phase, the pH value is adjusted to be larger than or equal to 12.0, the washing is carried out, the pH value is adjusted to be controlled within the range of 6.0-7.5, neutral washing is carried out, the water phase is transferred into the organic phase again after the pH value is smaller than or equal to 3.0, the diethylaminoethyl isothiourea hydrochloride is at the temperature of 40-45 ℃, and the phase separation interface is clear. Then, the mixture was washed with 26ml of a 35% aqueous methanol solution, and the solvent was distilled off under reduced pressure at 95℃and-0.095 MPa to obtain 35.98g of tiamulin, the purity of which was 96.01%.
Example 3
143G of bromochloroethane was charged into a 500ml reactor equipped with a stirring and condensing reflux apparatus, heated to 80℃and 93g of diethylamine was gradually added over 1 hour, then the reaction was maintained at 100℃for 3 hours, and the reaction solution was cooled to room temperature. Washing with 250ml of 30% K 2CO3, washing with 50ml of water with pH controlled at 6.0-7.5, and separating the aqueous phase to obtain the amino chloroethane.
80Ml of water and 72.6g of thiourea are added into the amino chloroethane, the reaction temperature is 65-80 ℃, the reaction is maintained for 1.5 hours, diethylaminoethyl isothiourea hydrochloride solution is generated, and the isothiourea salt content is detected to be 62.03 percent for standby.
200Ml of toluene solvent, 30g of pleuromutilin, 16g of p-toluenesulfonyl chloride and 15g of 32% of ionic membrane caustic soda are added into a 500ml reactor with stirring, the reaction temperature is 50 ℃, the reaction time is 1 hour, the water phase is separated, 224ml of pleuromutilin p-toluenesulfonate solution is obtained, and the content of pleuromutilin p-toluenesulfonate is detected to be 18.5%.
30G of diethylaminoethyl isothiourea hydrochloride solution, 0.3g of tetrabutylammonium bromide serving as a catalyst and 15g of 32% ionic membrane caustic soda are added into a ketone solution of pleuromutilin p-toluenesulfonate, and the reaction temperature is 50 ℃ and the reaction time is 1 hour, so that a reaction solution of tiamulin is obtained.
The tiamulin reaction liquid is separated into water phase, the pH value is adjusted to be larger than or equal to 12.0, the water phase is washed, the pH value is adjusted to be controlled within the range of 6.0-7.5, neutral washing is carried out, the water phase is transferred to the organic phase again after the pH value is smaller than or equal to 3.0, and the phase separation interface is clear at the temperature of diethylaminoethyl isothiourea hydrochloride of 40-45 ℃. Then, the mixture was washed with 35ml of a 15% aqueous methanol solution, and the solvent was distilled off under reduced pressure at 95℃and-0.095 MPa to obtain 36.33g of tiamulin, the purity of which was detected as 95.83%.
The above embodiments are provided to illustrate the technical concept and features of the present invention and are intended to enable those skilled in the art to understand the content of the present invention and implement the same, and are not intended to limit the scope of the present invention. All equivalent changes or modifications made in accordance with the spirit of the present invention should be construed to be included in the scope of the present invention.
Claims (5)
1. A method for preparing tiamulin from isothiourea salt and p-toluenesulfonic acid pleuromutilin ester, comprising the reaction of diethylamino chloroethane prepared from bromochloroethane and diethylamine with thiourea to react pleuromutilin with p-toluenesulfonyl chloride, characterized in that:
a, preparing diethylamino chloroethane, adding bromochloroethane into a reactor, heating, then gradually adding diethylamine, wherein the diethylamine feeding time is less than 1 hour, the mol ratio of bromochloroethane to diethylamine is 1:1.0-1.3, the reaction temperature is 100-120 ℃, the reaction time is maintained for 1-3 hours, the reaction solution is cooled to room temperature, the pH value is regulated to be more than or equal to 12.0, the reaction solution is washed, the pH value is controlled to be 6.0-7.5, and the diethylamino chloroethane is obtained by separating and discarding water phase;
b, preparing diethylaminoethyl isothiourea hydrochloride, adding thiourea and water into the diethylaminoethyl chloride prepared in the step a, wherein the molar ratio of the addition of the thiourea to the addition of the bromoethyl chloride in the step a is 1:1.0-1.1, the reaction temperature is 60-80 ℃, the reaction time is maintained for 1.5-2 hours, and 60-70% of diethylaminoethyl isothiourea hydrochloride solution is generated;
c, preparing pleuromutilin ester of the p-toluenesulfonic acid, adding ketone or benzene organic solvent which is methyl isobutyl ketone or methyl ethyl ketone into a reactor, adding pleuromutilin, p-toluenesulfonyl chloride and inorganic base, wherein the mol ratio of pleuromutilin to p-toluenesulfonyl chloride is 1:1.02-1.10, maintaining the pH value of a reaction system to be more than or equal to 12, reacting at 50-60 ℃ for 0.5-1 hour, and then separating an aqueous phase to obtain the pleuromutilin ester solution of the p-toluenesulfonic acid;
d, reacting isothiourea salt with pleuromutilin p-toluenesulfonate, adding the diethylaminoethyl isothiourea hydrochloride solution prepared in the step b into the pleuromutilin p-toluenesulfonate solution prepared in the step c, wherein the mol ratio of the pleuromutilin p-toluenesulfonate to the diethylaminoethyl isothiourea hydrochloride is 1:1.1-1.3, adding tetrabutylammonium bromide and inorganic base, and reacting for 0.5-1 hour at the temperature of 50-60 ℃ to obtain a tiamulin reaction solution;
e, extraction of tiamulin: the tiamulin reaction liquid is separated into water phases, then the water phases are sequentially subjected to alkaline washing, neutral washing and phase inversion to remove impurities, the pH value of the alkaline washing is larger than or equal to 12.0, the pH value of the neutral washing is controlled to be 6.0-7.5, the water phases are transferred into the water phases under the pH value of smaller than or equal to 3.0, then the water phases are transferred back to the organic phases, the system temperature is kept at 40-45 ℃ in the whole extraction process, the phase separation interface is clear, the impurities are removed by washing with a proportioning liquid of methanol and water, and finally the solvent is evaporated under reduced pressure for recycling, so that the tiamulin is obtained.
2. A process for the preparation of tiamulin from isothiourea salt and pleuromutilin ester of p-toluenesulfonic acid as claimed in claim 1, characterized in that: in the step d, the isothiourea salt and the pleuromutilin p-toluenesulfonate are added to prepare tiamulin, and the addition amount of tetrabutylammonium bromide is 0.5-1% of the addition amount of the pleuromutilin p-toluenesulfonate.
3. A process for the preparation of tiamulin from isothiourea salt and pleuromutilin ester of p-toluenesulfonic acid as claimed in claim 1, characterized in that: in the preparation of the pleuromutilin p-toluenesulfonate, the inorganic base is 32% of ionic membrane base, the adding amount of the 32% of ionic membrane base is 45% -55% of the adding amount of pleuromutilin, and in the preparation of the tiamulin by using the isothiourea salt and the pleuromutilin p-toluenesulfonate, the adding amount of the 32% of ionic membrane base is 30% -40% of the adding amount of the pleuromutilin p-toluenesulfonate.
4. A process for the preparation of tiamulin from isothiourea salt and pleuromutilin ester of p-toluenesulfonic acid as claimed in claim 1, characterized in that: in the purification of tiamulin in step e, the addition amount of the proportioning liquid of methanol and water is not less than 75% of the tiamulin.
5. A process for the preparation of tiamulin from isothiourea salts and pleuromutilin esters of p-toluenesulfonic acid as claimed in claim 1 or 4, characterized in that: the methanol and water mixture has methanol content of 10-40%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010475715.8A CN111574416B (en) | 2020-05-29 | 2020-05-29 | Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010475715.8A CN111574416B (en) | 2020-05-29 | 2020-05-29 | Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111574416A CN111574416A (en) | 2020-08-25 |
| CN111574416B true CN111574416B (en) | 2024-05-03 |
Family
ID=72121874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010475715.8A Active CN111574416B (en) | 2020-05-29 | 2020-05-29 | Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111574416B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113402431A (en) * | 2021-06-18 | 2021-09-17 | 青岛科技大学 | Preparation method of binary system tiamulin by one-pot method |
| CN120271487A (en) * | 2025-04-03 | 2025-07-08 | 山东胜利生物工程有限公司 | Preparation method of diethylaminoethyl isothiourea salt and preparation method of tiamulin |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG104156A (en) * | 2000-02-15 | 2001-08-31 | Любомир БОГДАНОВ | Method for the preparation of 2-diethylaminoethylisothiouronium chloride hydrochloride |
| BG105644A (en) * | 2001-06-25 | 2003-04-30 | "Биовет" Ад | Method for the preparation of thiamulin |
| CN101250145A (en) * | 2008-04-02 | 2008-08-27 | 苏州科技学院 | The preparation method of diethylaminoethanethiol |
| CN102675172A (en) * | 2012-04-27 | 2012-09-19 | 宁夏泰瑞制药股份有限公司 | Preparation method of tiamulin base |
| CN107759502A (en) * | 2017-10-11 | 2018-03-06 | 中国农业科学院兰州畜牧与兽药研究所 | A kind of preparation method of Tiamulin |
| CN108137621A (en) * | 2016-05-03 | 2018-06-08 | 株式会社Lg化学 | A New Method for Preparation of Aminosilane Compounds |
-
2020
- 2020-05-29 CN CN202010475715.8A patent/CN111574416B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG104156A (en) * | 2000-02-15 | 2001-08-31 | Любомир БОГДАНОВ | Method for the preparation of 2-diethylaminoethylisothiouronium chloride hydrochloride |
| BG105644A (en) * | 2001-06-25 | 2003-04-30 | "Биовет" Ад | Method for the preparation of thiamulin |
| CN101250145A (en) * | 2008-04-02 | 2008-08-27 | 苏州科技学院 | The preparation method of diethylaminoethanethiol |
| CN102675172A (en) * | 2012-04-27 | 2012-09-19 | 宁夏泰瑞制药股份有限公司 | Preparation method of tiamulin base |
| CN108137621A (en) * | 2016-05-03 | 2018-06-08 | 株式会社Lg化学 | A New Method for Preparation of Aminosilane Compounds |
| CN107759502A (en) * | 2017-10-11 | 2018-03-06 | 中国农业科学院兰州畜牧与兽药研究所 | A kind of preparation method of Tiamulin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111574416A (en) | 2020-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108341776B (en) | Process for synthesizing chloroquinate | |
| CN111574416B (en) | Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate | |
| CN110028399A (en) | A kind of preparation method of 2-methyl-4-chlorophenoxyacetic acid | |
| CN112592296B (en) | Method for producing sodium isethionate by continuous reaction | |
| CN112250600B (en) | Technological method for improving yield of N, N' -diisopropylcarbodiimide product | |
| CN112851543B (en) | Preparation method of methoxyamine hydrochloride and preparation method of N-methoxyacetamide | |
| CN104447509B (en) | A kind of preparation technology of tirofiban hydrochloride | |
| CN102875463A (en) | Synthesis method for high-quality and low-cost bispyrithione | |
| CN104098462B (en) | The method for splitting of the diphenyl-propionic acid racemoid of 2 hydroxyl, 3 methoxyl group 3,3 | |
| CN110028466B (en) | Method for producing dimorpholinyl diethyl ether | |
| CN118344334A (en) | Preparation method of vinyl sulfate | |
| CN102675232B (en) | Synthetic method of 4-(6-chlorine-quinoxaline-2-yloxy)-phenol | |
| CN110698381A (en) | Method for synthesizing N- (benzyloxycarbonyl) succinimide by one-pot two-phase method | |
| CN111362957B (en) | A kind of preparation method of icotinib key intermediate | |
| CN112125857A (en) | Preparation method of acipimox | |
| CN112479863A (en) | Method for preparing 2-methyl-4-chlorophenoxyacetic acid by catalytic chlorination of 2-methylphenoxyacetic acid | |
| CN103102327A (en) | Preparation method of rubber accelerator DZ (N,N-Dicyclohexyl-2-benzothiazolsulfene amide) | |
| CN109897075B (en) | Green synthesis method of sucralose-6-acetate | |
| CN113999171A (en) | Synthesis method of high-content dipyrithione | |
| CN110615858B (en) | Preparation method of sodium sugammadex intermediate | |
| CN113735747B (en) | Method for producing tiamulin by diethylaminoethanethiol synthetic solution | |
| CN113979901B (en) | Preparation method of C5 acetal sulfone | |
| CN113004168A (en) | Production process of methoxyamine for synthesizing furan ammonium salt | |
| CN117417340B (en) | A preparation method of 6-chloroimidazo[1,2-b]pyridazine-3-carbonitrile | |
| CN113024432A (en) | Preparation method of amisulpride pharmacopoeia impurities |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information |
Address after: 832000 No.3, Tianshan Road, No.94 community, Shihezi Development Zone, Shihezi City, Xinjiang Uygur Autonomous Region Applicant after: Xinjiang Shangni Biotechnology Co.,Ltd. Address before: 832000 No.3, Tianshan Road, No.94 community, Shihezi Development Zone, Shihezi City, Xinjiang Uygur Autonomous Region Applicant before: Xinjiang Zheda sunshine Biotechnology Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |